Elder Pharmaceuticals has rallied almost 5% to Rs 335 after the company said that it will form a joint venture (JV) company with the Japanese cosmetics major, Kose Corporation to manufacture and market cosmetic products for Indian market.
“As per the terms of agreement, Kose will hold 60% share in the JV Company, KOSE Elder (India) Private Limited and focus on the Indian market for manufacturing and selling cosmetics in India. Elder will hold 40% stake in the proposed JV,” Elder Pharmaceuticals said in a statement.
The stock opened at Rs 328 and touched high of Rs 340 on NSE. A combined 40,492 shares have changed hands on the counter till 0938 hours against an average 14,000 shares that were traded daily in past ten trading sessions on NSE and BSE.
“As per the terms of agreement, Kose will hold 60% share in the JV Company, KOSE Elder (India) Private Limited and focus on the Indian market for manufacturing and selling cosmetics in India. Elder will hold 40% stake in the proposed JV,” Elder Pharmaceuticals said in a statement.
The stock opened at Rs 328 and touched high of Rs 340 on NSE. A combined 40,492 shares have changed hands on the counter till 0938 hours against an average 14,000 shares that were traded daily in past ten trading sessions on NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%